# A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

> **NCT01847092** · PHASE2 · COMPLETED · sponsor: **Ardelyx** · enrollment: 154 (actual)

## Conditions studied

- Chronic Kidney Disease
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** AZD1722
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01847092
- **Lead sponsor:** Ardelyx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2020-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847092, "A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01847092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*